
INFUSYSTEM HOLDINGS INC
INFUNYSE AMERICANTrading Snapshot
- Day Range
- $12.36 โ $12.52
- 52-Week Range
- $7.29 โ $12.97
- Volume
- $2.43B
- Avg Volume
- $2.82B
- Shares Outstanding
- 20.2M
- Next Earnings
- Oct 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $143M
- Last Q Revenue
- $37M
- P/E Ratio
- 31.4
- P/S Ratio
- 1.7x
- EPS (TTM)
- $0.38
- Dividend Yield
- โ
Why Investors Own INFU
- โHigh-growth profile โ revenue up +12.2% YoY with expanding US Equity exposure.
- โHealthy economics โ 58% gross margin and 24% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About INFUSYSTEM HOLDINGS INC
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity
Astrana Health outperformed as the company results have continued to demonstrate that it was not taking advantage of loopholes within Medicare coding.
B. Riley Securities Reiterates Buy on InfuSystems Holdings, Raises Price Target to $20
B. Riley Securities analyst Anderson Schock reiterates InfuSystems Holdings (AMEX:INFU) with a Buy and raises the price target from $12 to $20.

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript
InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call August 4, 2026 9:00 AM EDTCompany ParticipantsCarrie Lachance - President, CEO & DirectorBarry...

12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular session. The company's market cap stands at $1.9 million. Adagio Medical Holdings (NASDAQ:ADGM) shares increased by
InfuSystem Holdings (NYSEARCA:INFU) Shares Jump After Q2 Earnings Beat
InfuSystem (INFU) Q2 EPS beats at $0.15 vs $0.11 est, revenue nearly in line; shares rise ~4.7% premarket on margin gains.

InfuSystems Holdings Reports Q2 2026 Results: Full Earnings Call Transcript
InfuSystems Holdings (AMEX:INFU) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga